"Akademiska sjukhuset erbjuder specialiserad och högspecialiserad vård lokalt, regionalt, nationellt och internationellt. Tillsammans med våra samverkanspartners följer vi patienten längs hela vårdkedjan även utanför vårt sjukhus. Vi är det ledande universitetssjukhuset i Sverige med fokus på bästa kliniska utfall för patienten. Sjukvårdens kvalitet, vårt nära samarbete med Uppsala universitet och vårt starka life science kluster är basen för vår internationellt konkurrenskraftiga kliniska forskning och utbildning."

During the past decade, Uppsala University Hospital conducted 255 clinical trials. In the 10-year time frame, 255 clinical trials started and 58 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 116 clinical trials started and 32 clinical trials were completed. i.e. 27.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uppsala University Hospital" #1 sponsor was "Uppsala University" with 78 trials, followed by "Uppsala University Hospital" with 22 trials sponsored, "Janssen Research & Development, LLC" with 16 trials sponsored, "Karolinska Institutet" with 16 trials sponsored and "Pfizer" with 16 trials sponsored. Other sponsors include 272 different institutions and companies that sponsored additional 162 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uppsala University Hospital" #1 collaborator was "Uppsala University Hospital" with 34 trials as a collaborator, "Karolinska University Hospital" with 16 trials as a collaborator, "Uppsala University" with 16 trials as a collaborator, "The Swedish Research Council" with 14 trials as a collaborator and "University Hospital, Linkoeping" with 13 trials as a collaborator. Other collaborators include 441 different institutions and companies that were collaborators in the rest 308 trials.

According to Clinical.Site data, the most researched conditions in "Uppsala University Hospital" are "Colorectal Cancer" (12 trials), "Breast Cancer" (11 trials), "Rectal Cancer" (9 trials), "Multiple Myeloma" (8 trials) and "Prostate Cancer" (8 trials). Many other conditions were trialed in "Uppsala University Hospital" in a lesser frequency.

Most popular intervention types in "Uppsala University Hospital" are "Drug" (229 trials), "Other" (65 trials), "Procedure" (58 trials), "Device" (39 trials) and "Biological" (37 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (57 trials), "Rituximab" (10 trials), "conventional surgery" (7 trials), "Bortezomib" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Uppsala University Hospital" are 376 trials for "All" genders, 28 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Uppsala University Hospital". undefined are not yet recruiting, 99 are recruiting, 47 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 202 completed trials in Uppsala University Hospital, 2 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Uppsala University Hospital, 31 "Phase 1" clinical trials were conducted, 103 "Phase 2" clinical trials and 133 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 104 trials that are defined as “Not Applicable".

Uppsala University Hospital has several departments that took part in Clinical trials: "Akademiska sjukhuset, Onkologkliniken" - 17 trials, "Dept infectious diseases" - 3 trials, "Kvinnokliniken, Akademiska sjukhuset" - 2 trials, "Samariterhemmets sjukhus" - 2 trials, "KFUE" - 2 trials, "Uppsala University Hospital, Dept of Paediatric Haematology and Oncology" - 2 trials